| Literature DB >> 28222164 |
Manuel Garcia-Garcia1,2, Marc Via1,2,3, Katarzyna Zarnowiec1,2, Iria SanMiguel1,2,3, Carles Escera1,2,3, Immaculada C Clemente1,2,3.
Abstract
Attention capture by potentially relevant environmental stimuli is critical for human survival, yet it varies considerably among individuals. A large series of studies has suggested that attention capture may depend on the cognitive balance between maintenance and manipulation of mental representations and the flexible switch between goal-directed representations and potentially relevant stimuli outside the focus of attention; a balance that seems modulated by a prefrontostriatal dopamine pathway. Here, we examined inter-individual differences in the cognitive control of attention through studying the effects of two single nucleotide polymorphisms regulating dopamine at the prefrontal cortex and the striatum (i.e., COMTMet108/158Val and ANKK1/DRD2TaqIA) on stimulus-driven attention capture. Healthy adult participants (N = 40) were assigned to different groups according to the combination of the polymorphisms COMTMet108/158Val and ANKK1/DRD2TaqIA, and were instructed to perform on a well-established distraction protocol. Performance in individuals with a balance between prefrontal dopamine display and striatal receptor density was slowed down by the occurrence of unexpected distracting events, while those with a rather unbalanced dopamine activity were able maintain task performance with no time delay, yet at the expense of a slightly lower accuracy. This advantage, associated to their distinct genetic profiles, was paralleled by an electrophysiological mechanism of phase-resetting of gamma neural oscillation to the novel, distracting events. Taken together, the current results suggest that the epistatic interaction between COMTVal108/158Met and ANKK1/DRD2 TaqIa genetic polymorphisms lies at the basis of stimulus-driven attention capture.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28222164 PMCID: PMC5319755 DOI: 10.1371/journal.pone.0172362
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Task performance in all four groups.
(a) Accuracy was lower in trials with novel sounds in comparison to those with standard sounds in all four groups (*, p<0.005). Notice the inverted-U shape of accuracy in the two trial types for the four groups arranged in the panel according to their levels of PFC-Striatum DA balance. (b) Response times in standard and novel trials (*, p<0.03). Notice that two groups displayed similar RT (i.e., ValA1- and MetA1+) in standard and novel trials, whereas the other two groups (i.e., ValA1+ and MetA1-) showed larger RT in novel than in standard trials. (c) Distribution of mean accuracy and RT slowing in all single individuals. Notice that the black symbols, representing individuals in the balanced groups, are mainly distributed on the upper right part of the plot, showing larger RT slowing after novel relative to standard sounds, but better mean accuracy than the unbalanced groups. In contrast, individuals from the unbalanced groups (white symbols) were distributed on the lower part of the graph as their accuracy was slightly worse, and along the Y axis because their RTs were not delayed by the novel sounds.
Fig 3RT, amplitude and PLF of 40 Hz oscillatory activity for novel relative to standard trials.
(a) Left panel shows the mean RT for novel compared to standard trials; notice that only the ValA1+ and MetA1- groups had larger RT for novel as compared to standard trials. Middle panel shows the increase in amplitude of neural oscillations at 40 Hz locked to novel sounds compared to that locked to standard sounds at Cz. Notice that amplitudes were larger after novel compared to standard sounds in all four groups. Right panel shows the increase of the PLF of neural oscillations at 40 Hz locked to novels sounds relative to that locked to standard sounds at Cz. Notice that PLF was larger after novel compared to standard trials in only the ValA1- and MetA1+ groups. (b) Scatter plots of individual values for RT (left panel), amplitude of the evoked 40 Hz oscillatory activity (middle panel), and PLF of the 40 Hz oscillatory activity (right panel). (*, p<0.05; **, p<0.01; ***, p<0.001; n.s., p>0.05).
Fig 2Standardized PLF values for novel and standard trials.
Plots of standardized PLF values for novel and standard trials are shown for all four groups’ Cz for frequencies from 30 to 55 Hz. ValA1- and MetA1+ groups showed enhanced PLF in novel compared to standard trials around 100 ms post-sound onset, whereas ValA1+ and MetA1- groups had similar PLF values to both stimulus types.